198 related articles for article (PubMed ID: 32807036)
1. Wnt/β-Catenin and Hippo Pathway Deregulation in Mammary Tumors of Humans, Dogs, and Cats.
Sammarco A; Gomiero C; Sacchetto R; Beffagna G; Michieletto S; Orvieto E; Cavicchioli L; Gelain ME; Ferro S; Patruno M; Zappulli V
Vet Pathol; 2020 Nov; 57(6):774-790. PubMed ID: 32807036
[TBL] [Abstract][Full Text] [Related]
2. A preliminary investigation of the role of the transcription co-activators YAP/TAZ of the Hippo signalling pathway in canine and feline mammary tumours.
Beffagna G; Sacchetto R; Cavicchioli L; Sammarco A; Mainenti M; Ferro S; Trez D; Zulpo M; Michieletto S; Cecchinato A; Goldschmidt M; Zappulli V
Vet J; 2016 Jan; 207():105-111. PubMed ID: 26626094
[TBL] [Abstract][Full Text] [Related]
3. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
[TBL] [Abstract][Full Text] [Related]
4. Deregulation of the Hippo pathway in mouse mammary stem cells promotes mammary tumorigenesis.
Li H; Gumbiner BM
Mamm Genome; 2016 Dec; 27(11-12):556-564. PubMed ID: 27601049
[TBL] [Abstract][Full Text] [Related]
5. Hippo signaling pathway in companion animal diseases, an under investigated signaling cascade.
Budel SJ; Penning MM; Penning LC
Vet Q; 2021 Dec; 41(1):172-180. PubMed ID: 33945400
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.
Guillemette S; Rico C; Godin P; Boerboom D; Paquet M
J Mammary Gland Biol Neoplasia; 2017 Sep; 22(3):203-214. PubMed ID: 28822004
[TBL] [Abstract][Full Text] [Related]
7. Statins downregulate YAP and TAZ and exert anti-cancer effects in canine mammary tumour cells.
Vigneau AL; Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2022 Jun; 20(2):437-448. PubMed ID: 34881506
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of expression of the Wnt signaling components in canine mammary tumors via RT
Yu F; Rasotto R; Zhang H; Pei S; Zhou B; Yang X; Jin Y; Zhang D; Lin D
J Vet Sci; 2017 Sep; 18(3):359-367. PubMed ID: 27586466
[TBL] [Abstract][Full Text] [Related]
9. The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer.
Di Benedetto A; Mottolese M; Sperati F; Ercolani C; Di Lauro L; Pizzuti L; Vici P; Terrenato I; Sperduti I; Shaaban AM; Sundara-Rajan S; Barba M; Speirs V; De Maria R; Maugeri-Saccà M
Oncotarget; 2016 Jul; 7(28):43188-43198. PubMed ID: 27248471
[TBL] [Abstract][Full Text] [Related]
10. [Crosstalk of Hippo/YAP and Wnt/β-catenin pathways].
Xu F; Zhang J; Ma D
Yi Chuan; 2014 Feb; 36(2):95-102. PubMed ID: 24846937
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic trial of fluvastatin in a cell line xenograft model of canine mammary gland cancer.
Atmane MI; Vigneau AL; Beaudry F; Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2023 Dec; 21(4):634-645. PubMed ID: 37709554
[TBL] [Abstract][Full Text] [Related]
12. Interacting network of Hippo, Wnt/β-catenin and Notch signaling represses liver tumor formation.
Kim W; Khan SK; Yang Y
BMB Rep; 2017 Jan; 50(1):1-2. PubMed ID: 27881216
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-to-Mesenchymal Transition and Phenotypic Marker Evaluation in Human, Canine, and Feline Mammary Gland Tumors.
Sammarco A; Gomiero C; Beffagna G; Cavicchioli L; Ferro S; Michieletto S; Orvieto E; Patruno M; Zappulli V
Animals (Basel); 2023 Feb; 13(5):. PubMed ID: 36899736
[TBL] [Abstract][Full Text] [Related]
14. Differential requirement of Hippo cascade during CTNNB1 or AXIN1 mutation-driven hepatocarcinogenesis.
Liang B; Wang H; Qiao Y; Wang X; Qian M; Song X; Zhou Y; Zhang Y; Shang R; Che L; Chen Y; Huang Z; Wu H; Monga SP; Zeng Y; Calvisi DF; Chen X; Chen X
Hepatology; 2023 Jun; 77(6):1929-1942. PubMed ID: 35921500
[TBL] [Abstract][Full Text] [Related]
15. Mammalian sterile 20-like kinase 1/2 inhibits the Wnt/β-catenin signalling pathway by directly binding casein kinase 1ε.
Xu F; Wang YL; Chang JJ; Du SC; Diao L; Jiang N; Wang HJ; Ma D; Zhang J
Biochem J; 2014 Feb; 458(1):159-69. PubMed ID: 24180524
[TBL] [Abstract][Full Text] [Related]
16. Crosslinked Extracellular Matrix Stiffens Human Trabecular Meshwork Cells Via Dysregulating β-catenin and YAP/TAZ Signaling Pathways.
Yemanyi F; Vranka J; Raghunathan VK
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):41. PubMed ID: 32832971
[TBL] [Abstract][Full Text] [Related]
17. A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling.
Imajo M; Miyatake K; Iimura A; Miyamoto A; Nishida E
EMBO J; 2012 Mar; 31(5):1109-22. PubMed ID: 22234184
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Real-Time PCR to Measure YAP/TAZ Activity in Human Cells.
Cao X; Zhao B
Methods Mol Biol; 2019; 1893():137-152. PubMed ID: 30565132
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression.
Luu AK; Schott CR; Jones R; Poon AC; Golding B; Hamed R; Deheshi B; Mutsaers A; Wood GA; Viloria-Petit AM
BMC Vet Res; 2018 Nov; 14(1):365. PubMed ID: 30477496
[TBL] [Abstract][Full Text] [Related]
20. LKB1 inhibits the proliferation of gastric cancer cells by suppressing the nuclear translocation of Yap and β-catenin.
Ma LG; Bian SB; Cui JX; Xi HQ; Zhang KC; Qin HZ; Zhu XM; Chen L
Int J Mol Med; 2016 Apr; 37(4):1039-48. PubMed ID: 26936013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
